2018 (v1)
Publication
No description
Uploaded on: April 14, 2023
B
F
Last name: BARCHIESI
First name: Francesco
No description
Objectives: Bezlotoxumab (BEZ) is a promising tool for preventing the recurrence of Clostridioides difficile infection (rCDI). The aim of the study was to emulate, in a real-world setting, the MODIFY trials in a cohort of participants with multiple risk factors for rCDI treated with BEZ in addition to the standard of care (SoC) versus SoC...